|Articles|January 17, 2017
Renova Therapeutics Selects Worldwide Clinical Trials
Renova Therapeutics has announced the selection of Worldwide Clinical Trials as its CRO for an upcoming gene therapy study.
Advertisement
Renova Therapeutics has announced the selection of Worldwide Clinical Trials as its CRO for an upcoming gene therapy study. Worldwide Clinical Trials will support the Phase III study of RT-100 AC6 gene transfer for the treatment of patients with reduced ejection fraction heart failure.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
FDA Outlines New Superiority Standard for Future CAR-T Approvals
3
Integrating Trials into Routine Care
4
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
